Provention Bio Inc. (PRVB) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Provention Bio Inc.

NASDAQ: PRVB · Real-Time Price · USD
24.98
0.00 (0.00%)
At close: Apr 26, 2023, 10:00 PM

Provention Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-33.28M -28.63M -29.69M -21.97M -25.83M -27.02M -29.14M -32.44M
Depreciation & Amortization
811K 144K 136K 137K 137K 96K 81K 73K
Stock-Based Compensation
9.21M 3.3M 3.2M 3.31M 2.58M 3.13M 3.27M 2.86M
Other Working Capital
15.27M 3.02M -630K -344K -385K -1.38M -17K 12.12M
Other Non-Cash Items
-367K 72K 121K 138K 121K 57K 134K 189K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
15.64M 1.15M -2.21M 3.35M -472K -1.61M -4.43M 12.83M
Operating Cash Flow
-7.97M -23.97M -28.44M -15.03M -23.46M -25.35M -30.09M -16.49M
Capital Expenditures
-373K -196K -226K n/a -42K 6K -675K -250K
Cash Acquisitions
n/a n/a n/a n/a 31.1M n/a n/a n/a
Purchase of Investments
-53.9M -49.18M n/a n/a -38.96M n/a -3.93M -12.4M
Sales Maturities Of Investments
18M 3.15M n/a 9.6M 1.31M 12.9M 6.12M 4.82M
Other Investing Acitivies
-15M n/a n/a n/a -31.1M n/a n/a n/a
Investing Cash Flow
-51.27M -46.23M -226K 9.6M -37.69M 12.91M 1.52M -7.83M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
905K 114.69M 11.63M 2.15M 102.33M n/a n/a 102.38M
Financial Cash Flow
905K 114.69M 11.63M 2.15M n/a n/a n/a 102.38M
Net Cash Flow
-58.34M 44.5M -17.03M -3.28M -61.15M -12.44M -28.58M 78.06M
Free Cash Flow
-8.35M -24.16M -28.66M -15.03M -23.5M -25.34M -30.77M -16.74M